Gene · 970
Papers4,349
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 4,349
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Does Diffusely Infiltrating Lobular Carcinoma of the Breast Arise from Epithelial-Mesenchymal Hybrid Cells? | Int J Mol Sci | 2023 | 37445938 | PubTator, text mining | PubMed |
| Endosome Traffic Modulates Pro-Inflammatory Signal Transduction in CD4+ T Cells-Implications for the Pathogenesis of Systemic Lupus Erythematosus. | Int J Mol Sci | 2023 | 37445926 | PubTator, text mining | PubMed |
| Laboratory Findings and Biomarkers in Long COVID: What Do We Know So Far? Insights into Epidemiology, Pathogenesis, Therapeutic Perspectives and Challenges. | Int J Mol Sci | 2023 | 37445634 | PubTator, text mining | PubMed |
| Fine-Tuning through Generations: Advances in Structure and Production of CAR-T Therapy. | Cancers (Basel) | 2023 | 37444586 | PubTator, text mining | PubMed |
| Additive effects of booster mRNA vaccination and SARS-CoV-2 Omicron infection on T cell immunity across immunocompromised states. | Sci Transl Med | 2023 | 37437015 | PubTator, text mining | PubMed |
| A simplified protocol for gene expression-based biological dosimetry using peripheral whole blood. | Int J Radiat Biol | 2023 | 37436720 | PubTator, text mining | PubMed |
| Lead exposure suppresses the Wnt3a/β-catenin signaling to increase the quiescence of hematopoietic stem cells via reducing the expression of CD70 on bone marrow-resident macrophages. | Toxicol Sci | 2023 | 37436718 | PubTator, text mining | PubMed |
| Identification of N7-methylguanosine-related lncRNAs for the risk stratification of hepatocellular carcinoma. | J Gastrointest Oncol | 2023 | 37435203 | PubTator, text mining | PubMed |
| Evaluation of hypereosinophilia in a case of FLT3-mutant acute myeloid leukemia treated with gilteritinib. | Cold Spring Harb Mol Case Stud | 2023 | 37433680 | PubTator, text mining | PubMed |
| Targeting Wnt/β-Catenin Pathway by Flavonoids: Implication for Cancer Therapeutics. | Nutrients | 2023 | 37432240 | PubTator, text mining | PubMed |
| Lymph node metastasis-related gene signature shows good performance in predicting prognosis and immune infiltration in cervical cancer. | Front Oncol | 2023 | 37427104 | PubTator, text mining | PubMed |
| How molecular advances may improve the diagnosis and management of PTCL patients. | Front Oncol | 2023 | 37427095 | PubTator, text mining | PubMed |
| Chimeric Antigen Receptor (CAR) T-Cell Therapy for Patients with Lung Cancer: Current Perspectives. | Onco Targets Ther | 2023 | 37425981 | PubTator, text mining | PubMed |
| Immune response and treatment targets of chronic hepatitis B virus infection: innate and adaptive immunity. | Front Cell Infect Microbiol | 2023 | 37424786 | PubTator, text mining | PubMed |
| TERC haploid cell reprogramming: a novel therapeutic strategy for aplastic anemia. | Mol Med | 2023 | 37424004 | PubTator, text mining | PubMed |
| Harnessing the potential of CAR-T cell therapy: progress, challenges, and future directions in hematological and solid tumor treatments. | J Transl Med | 2023 | 37420216 | PubTator, text mining | PubMed |
| The use of RNA-based treatments in the field of cancer immunotherapy. | Mol Cancer | 2023 | 37420174 | PubTator, text mining | PubMed |
| Immunotherapy for nasopharyngeal carcinoma: Current status and prospects (Review). | Int J Oncol | 2023 | 37417358 | PubTator, text mining | PubMed |
| Construction and validation of stemness-related lncRNA pair signature for predicting prognosis in colorectal cancer. | J Cancer Res Clin Oncol | 2023 | 37410143 | PubTator, text mining | PubMed |
| A novel stemness classification in acute myeloid leukemia by the stemness index and the identification of cancer stem cell-related biomarkers. | Front Immunol | 2023 | 37409118 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/970/papers?page=32